Siblings Conference Papers/Meeting Abstract [41/48] Papers [0/1] Patents [0/11] Collection Statistics Item counts issued in 3 years:0(0.00%) Items With Fulltext:193(99.48%) Download counts of the item Download times greater than 0:193(100.00%) Download times greater than 100:193(100.00%) Total Bitstream Download Counts:122370(83.64%) Last Update: 2024-11-28 14:58 Top Upload Loading... Top Download Loading... Recent Submissions Identification of prognostic biomar... A novel NRF2/ARE inhibitor gossypol... Targeting lysosomal cysteine protea... c-MYC-directed NRF2 drives malignan... Ephrin A4-ephrin receptor A10 signa... Phase I dose-escalation study of SC... Germline susceptibility variants im... Index of cancer-associated fibrobla... The SMAC mimetic LCL161 is a direct... The tumor suppressor TGFBR3 blocks ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-50 of 194. (4 Page(s) Totally) 1 2 3 4 > >> View [10|25|50] records per page

Date	Title	Relation
2021-12-14	A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells	Journal of Food and Drug Analysis. 2021 Dec 14;29(4):638-652.
2021-11-16	Identification of prognostic biomarkers originating from the tumor stroma of betel quid-associated oral cancer tissues	Frontiers in Oncology. 2021 Nov 16;11:Article number 769665.
2021-04	Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors	Oncologist. 2021 Apr;26(4):e567-e579.
2021-03-11	c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation	Theranostics. 2021 Mar 11;11(11):5232-5247.
2021-03-04	Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy	Theranostics. 2021 Mar 4;11(10):4672-4687.
2021-01-12	Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells	Scientific Reports. 2021 Jan 12;11:Article number 644.
2020-08	The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells	Toxicology and Applied Pharmacology. 2020 Aug;401:Article number 115080.
2020-07-17	Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer[Erratum:Scientific Reports. 2019 Mar;9:Article number 3931.]	Scientific Reports. 2020 Jul 17;10:Article number 12216.
2020-06-28	Index of cancer-associated fibroblasts is superior to the epithelial–mesenchymal transition score in prognosis prediction	Cancers. 2020 Jun 28;12(7):Article number 1718.
2020-06	Pharmacological inhibition of cathepsin S suppresses abdominal aortic aneurysm in mice	European Journal of Vascular and Endovascular Surgery. 2020 Jun;59(6):990-999.
2020-05-27	The tumor suppressor TGFBR3 blocks lymph node metastasis in head and neck cancer	Cancers. 2020 May 27;12(6):Article number 1375.
2020-04-02	MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer	Journal of Biomedical Science. 2020 Apr 2;27:Article number 46.
2020-03-31	Discoidin domain receptor-1 (DDR1) is involved in angiolymphatic invasion in oral cancer	Cancers. 2020 Mar 31;12(4):Article number 841.
2019-12	Lysosomal cysteine protease cathepsin S is involved in cancer cell motility by regulating store-operated Ca(2+) entry	Biochimica et Biophysica Acta. Molecular Cell Research. 2019 Dec;1866(12):Article number 118517.
2019-08-24	New insights into mechanisms of cisplatin resistance: From tumor cell to microenvironment	International Journal of Molecular Sciences. 2019 Aug 24;20(17):Article number 4136.
2019-06-01	Laminin gamma2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via intergrin alpha3-dependent uptake by lymphatic endothelial cells	International Journal of Cancer. 2019 Jun 1;144(11):2795-2810.
2019-06	Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial	Head and Neck. 2019 Jun;41(6):1703-1712.
2019-06	Validation of alcohol flushing questionnaire to identify ALDH2 status in a case-control study of head and neck cancer	Alcoholism, Clinical and Experimental Research. 2019 Jun;43(6):1225-1233.
2019-04	Oral hygiene and the overall survival of head and neck cancer patients	Cancer Medicine. 2019 Apr;8(4):1854-1864.
2019-03-20	TNF-alpha-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility	PLoS ONE. 2019 Mar 20;14(3):Article number e0213463.
2019-03	Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer	Scientific Reports. 2019 Mar;9:Article number 3931.
2019-02	The influence of prediagnosis alcohol consumption and the polymorphisms of ethanol metabolizing genes on the survival of head and neck cancer patients	Cancer Epidemiology, Biomarkers and Prevention. 2019 Feb;28(2):248-257.
2019-01-15	1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase	European Journal of Medicinal Chemistry. 2019 Jan 15;162:612-630.
2018-12	Ubiquitin-conjugating enzyme E2 B regulates the ubiquitination of O(6)-methylguanine-DNA methyltransferase and BCNU sensitivity in human nasopharyngeal carcinoma cells	Biochemical Pharmacology. 2018 Dec;158:327-338.
2018-11	Alpha-tubulin acetyltransferase/MEC-17 regulates cancer cell migration and invasion through epithelial-mesenchymal transition suppression and cell polarity disruption	Scientific Reports. 2018 Nov;8:Article number 17477.
2018-06-15	2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition [Erratum: Organic and Biomolecular Chemistry. 2016 Jan;14(2):716-723.]	Organic and biomolecular chemistry. 2018 Jun 15;16:4734.
2018-06	The interplay between oral microbiome, lifestyle factors, and genetic polymorphisms in the risk of oral squamous cell carcinoma	Carcinogenesis. 2018 Jun;39(6):778-787.
2018-05-29	Homoharringtonine induced immune alteration for an efficient anti-tumor response in mouse models of non-small cell lung adenocarcinoma expressing Kras mutation	Scientific Reports. 2018 May 29;8:Article number 8216.
2018-03-28	Novel microtubule inhibitor MPT0B098 inhibits hypoxia-induced epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma	Journal of Biomedical Science. 2018 Mar 28;25:Article number 28.
2017-12-15	Skin Delivery of Clec4a small hairpin RNA Elicited an effective antitumor response by enhancing CD8(+) immunity in vivo	Molecular Therapy-Nucleic Acids. 2017 Dec 15;9:419-427.
2017-12	Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells	Free Radical Biology and Medicine. 2017 Dec;113:505-518.
2017-10-24	Investigating the association between diet and risk of head and neck cancer in Taiwan	Oncotarget. 2017 Oct 24;8(58):98865-98875.
2017-10	Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis via up-regulation of fibronectin	FASEB Journal. 2017 Oct;31(10):4265-4276.
2017-10	The c.1085A>G genetic variant of CSF1R gene regulates tumor immunity by altering the proliferation, polarization, and function of macrophages	Clinical Cancer Research. 2017 Oct;23(20):6021-6030.
2017-08-29	Investigating the association between alcohol and risk of head and neck cancer in Taiwan	Scientific Reports. 2017 Aug 29;7:Article number 9701.
2017-06-20	Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways	Scientific Reports. 2017 Jun 20;7:Article number 3879.
2017-04-21	Regular recreational physical activity and risk of head and neck cancer	BMC Cancer. 2017 Apr 21;17:Article number 286.
2017-03-28	Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy	Scientific Reports. 2017 Mar 28;7:Article number 45366.
2017-01-25	Parathyroid hormone-like hormone is a poor prognosis marker of head and neck vancer and promotes cell growth via RUNX2 regulation	Scientific Reports. 2017 Jan 25;7:Article number 41131.
2016-12-15	Dysregulation of RUNX2/activin-A axis upon miR-376c downregulation promotes lymph node metastasis in head and neck squamous cell carcinoma	Cancer Research. 2016 Dec 15;76(24):7140-7150.
2016-10-25	A comprehensive analysis on the association between tobacco-free Betel Quid and risk of Head and Neck Cancer in Taiwanese men	PLoS ONE. 2016 Oct 25;11(10):Article number e0164937.
2016-09	Up-regulation of miR-455-5p by the TGF-beta–SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B	Journal of Pathology. 2016 Sep;240(1):38-49.
2016-08-24	A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment	Journal of Biomedical Science. 2016 Aug 24;23:Article number 64.
2016-08	Desferal regulates hCtr1 and transferrin receptor expression through Sp1 and exhibits synergistic cytotoxicity with platinum drugs in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo	Oncotarget. 2016 Aug;7(31):49310-49321.
2016-07-08	Cathepsin S attenuates endosomal EGFR signalling: A mechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors	Scientific Reports. 2016 Jul 8;6:Article number 29256.
2016-07-01	MPT0B098, a microtubule inhibitor, suppresses JAK2/STAT3 signaling pathway through modulation of SOCS3 stability in oral squamous cell carcinoma	PLoS ONE. 2016 Jul 1;11(7):Article number e0158440.
2016-07	Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer	Expert Opinion on Pharmacotherapy. 2016 Jul;17(10):1413-1420.
2016-06	IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma	Molecular Oncology. 2016 Jun;10(6):895-909.
2016-05	Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma	Molecular Carcinogenesis. 2016 May;55(5):499-513.
2016-03	miR-520h is crucial for DAPK2 regulation and breast cancer progression	Oncogene. 2016 Mar 3;35(9):1134-1142.

Showing items 1-50 of 194. (4 Page(s) Totally) 1 2 3 4 > >> View [10|25|50] records per page